BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7171971)

  • 41. Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint.
    Doubilet P; Donowitz M; Pauker SG
    Med Decis Making; 1982; 2(2):147-60. PubMed ID: 7167043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological detection of occult blood in bowel cancer patients.
    Kapparis A; Frommer D
    Br J Cancer; 1985 Dec; 52(6):857-61. PubMed ID: 3935151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colorectal cancer screening. Faecal occult blood tests.
    McDonald C
    Aust Fam Physician; 1985 Apr; 14(4):273, 276-7. PubMed ID: 4015528
    [No Abstract]   [Full Text] [Related]  

  • 45. Occult blood tests and colorectal tumours.
    Ribet A; Frexinos J; Escourrou J; Delpu J
    Lancet; 1980 Feb; 1(8165):417. PubMed ID: 6101861
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients.
    Pye G; Jackson J; Thomas WM; Hardcastle JD
    Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnostic security of occult blood tests in feces in early diagnosis of colorectal carcinoma in neoplasm screening].
    Heinrich HC
    Dtsch Med Wochenschr; 1979 Oct; 104(42):1496-7. PubMed ID: 498967
    [No Abstract]   [Full Text] [Related]  

  • 48. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test.
    Moss SM; Hardcastle JD; Coleman DA; Robinson MH; Rodrigues VC
    Int J Epidemiol; 1999 Jun; 28(3):386-90. PubMed ID: 10405838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
    Logan RF; Little J; Hawtin PG; Hardcastle JD
    BMJ; 1993 Jul; 307(6899):285-9. PubMed ID: 8374373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Faecal occult blood tests in adenoma detection.
    Kronborg O
    Eur J Cancer Prev; 1993 Jun; 2 Suppl 2():107-10. PubMed ID: 8364366
    [No Abstract]   [Full Text] [Related]  

  • 51. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
    Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
    Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Faecal occult blood testing: sensitivity and specificity.
    Macrae FA
    Br J Surg; 1985 Sep; 72 Suppl():S67-9. PubMed ID: 3899266
    [No Abstract]   [Full Text] [Related]  

  • 53. Assessment of Fecatest and Haemoccult for faecal occult blood testing.
    Lee FI; Costello FT
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):938. PubMed ID: 6811077
    [No Abstract]   [Full Text] [Related]  

  • 54. [Early diagnosis of colorectal carcinoma. Diagnostic security of occult blood in feces in carcinoma mass screening].
    Heinrich HC
    Dtsch Med Wochenschr; 1980 Apr; 105(14):490. PubMed ID: 7363810
    [No Abstract]   [Full Text] [Related]  

  • 55. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

  • 56. The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study.
    Gilbertsen VA; McHugh R; Schuman L; Williams SE
    Cancer; 1980 Jun; 45(11):2899-2901. PubMed ID: 7379021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for colorectal cancer.
    Sterchi JM
    South Med J; 1979 Sep; 72(9):1144-6. PubMed ID: 472841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Editorial: Colorectal cancer: A continuing challenge.
    Leffall LD
    Am J Surg; 1974 Sep; 128(3):315-6. PubMed ID: 4412926
    [No Abstract]   [Full Text] [Related]  

  • 60. [Detection of colo-rectal tumors. Valve of the guaiac clinical test].
    Baumel H; Giraudon M; Deizonne B; Rey MH
    Med Chir Dig; 1979; 8(4):307-12. PubMed ID: 502623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.